We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$32.6B
AUM Growth
+$5.94B
Cap. Flow
+$4.68B
Cap. Flow %
14.35%
Top 10 Hldgs %
28.49%
Holding
5,277
New
882
Increased
1,986
Reduced
1,465
Closed
789

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$248M
2
NVDA icon
NVIDIA
NVDA
+$246M
3
TSLA icon
Tesla
TSLA
+$236M
4
AVGO icon
Broadcom
AVGO
+$209M
5
PLTR icon
Palantir
PLTR
+$171M

Sector Composition

Rank Sector Weight
1 Technology 7.32%
2 Healthcare 7.04%
3 Consumer Discretionary 5.39%
4 Industrials 4.55%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSNC icon
4151
CALL
SS&C Technologies
SSNC
$18.9B
$26.2K ﹤0.01%
+300
New +$25.6K
INCY icon
4152
Incyte
INCY
$25.4B
$26.2K ﹤0.01%
265
-3,452
-93% -$334K
VERI icon
4153
PUT
Veritone
VERI
$92.9M
$26K ﹤0.01%
5,600
-13,500
-71% -$72.6K
FHI icon
4154
PUT
Federated Hermes
FHI
$4.56B
$26K ﹤0.01%
500
-2,500
-83% -$127K
QSI icon
4155
CALL
Quantum-Si Incorporated
QSI
$153M
$26K ﹤0.01%
+23,600
New +$38.4K
UMC icon
4156
CALL
United Microelectronic
UMC
$42.9B
$25.9K ﹤0.01%
3,300
-10,000
-75% -$75.9K
MSGS icon
4157
PUT
Madison Square Garden
MSGS
$9.59B
$25.9K ﹤0.01%
100
-2,100
-95% -$478K
TXG icon
4158
10x Genomics
TXG
$5.88B
$25.7K ﹤0.01%
+1,577
New +$23.8K
IONS icon
4159
Ionis Pharmaceuticals
IONS
$8.93B
$25.7K ﹤0.01%
+325
New +$24.5K
VITL icon
4160
PUT
Vital Farms
VITL
$586M
$25.6K ﹤0.01%
800
-22,300
-97% -$785K
TPG icon
4161
CALL
TPG
TPG
$6.76B
$25.5K ﹤0.01%
400
-2,100
-84% -$124K
VERA icon
4162
CALL
Vera Therapeutics
VERA
$2.33B
$25.3K ﹤0.01%
+500
New +$17.8K
ING icon
4163
PUT
ING
ING
$92.9B
$25.2K ﹤0.01%
900
-12,000
-93% -$309K
COO icon
4164
Cooper Companies
COO
$14.2B
$25K ﹤0.01%
305
-180,482
-100% -$13.5M
EVOXW
4165
Evolution Global Acquisition Corp Warrants
EVOXW
$4.44M
$24.9K ﹤0.01%
+56,550
New +$21.5K
SHEL icon
4166
Shell
SHEL
$244B
$24.8K ﹤0.01%
338
-1,645
-83% -$121K
OGI
4167
Organigram Holdings
OGI
$131M
$24.5K ﹤0.01%
+14,612
New +$25.1K
ARCT icon
4168
PUT
Arcturus Therapeutics
ARCT
$165M
$24.5K ﹤0.01%
4,000
-1,700
-30% -$18.4K
WAB icon
4169
Wabtec
WAB
$49.3B
$24.3K ﹤0.01%
+114
New +$23.4K
MNSO icon
4170
MINISO
MNSO
$3.88B
$24.3K ﹤0.01%
1,296
-71,427
-98% -$1.48M
RXT icon
4171
PUT
Rackspace Technology
RXT
$960M
$24.3K ﹤0.01%
25,000
CGNX icon
4172
Cognex
CGNX
$9.62B
$23.9K ﹤0.01%
+663
New +$26.8K
PLUG icon
4173
PUT
Plug Power
PLUG
$2.65B
$23.8K ﹤0.01%
12,100
+12,000
+12,000% +$31.3K
POR icon
4174
Portland General Electric
POR
$5.82B
$23.7K ﹤0.01%
+493
New +$23.3K
LOVE icon
4175
PUT
LoveSac
LOVE
$242M
$23.6K ﹤0.01%
1,600
-3,700
-70% -$52.3K

Similar funds

Walleye Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Walleye Capital held 5,277 positions worth $32.6B, up 22% from $26.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Walleye Capital deployed $4.68B of net new capital in Q4 2025, opening 882 new positions and adding to 1,986 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 6,616,070 shares worth $4.53B.

By sector, the portfolio is most concentrated in Technology at 7.3% of assets, down from 9.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $248M trimmed.

  • Walleye Capital's largest Q4 2025 buy was iShares Core S&P 500 ETF: 6,616,070 shares worth $4.53B.
  • Walleye Capital added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $136M increase.
  • Walleye Capital's biggest Q4 2025 reduction was Apple, cutting an estimated $248M.
  • Walleye Capital fully exited Mohawk Industries in Q4 2025, selling an estimated $39.8M.
  • Walleye Capital's ten largest holdings make up 28% of its $32.6B portfolio in Q4 2025.
  • Walleye Capital opened 882 new positions and closed 789 in Q4 2025.
  • Walleye Capital's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.